美股異動 | 柯達市前一度跌49%,涉嫌資訊披露違規
uSMART友信智投8月10日消息,週一美股市前,近期暴升暴跌"妖股"柯達一度跌49.12%,截至北京時間16:25分,柯達市前跌38.31%,報9.18美元。
據CNBC報導,美國國際發展金融公司表示,柯達與美國政府達成的價值 7.65 億美元藥物原料貸款協定已被擱置,原因是針對柯達“最近有不當行為的指控”。除非這些指控被證明是不存在的,否則不會採取進一步行動。
美國當地時間7月28日,柯達獲得了美國聯邦政府7.65億美元的貸款,這筆錢來自於美國國際發展金融公司,是美國政府依據《國防生產法》下發的首筆此類貸款。柯達計畫使用這筆資金生產一些仿製藥的原料藥。其中包括曾被特朗普強烈推薦的羥氯喹。消息公佈後,柯達股價在上週三個交易日內暴升超過1000%,隨後股價又經歷了暴跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.